title: A generic cyclosporine development program.
authors.affiliation: SangStat Medical Corporation, Menlo Park, California, USA.
authors.forename: T J
authors.initials: TJ
authors.lastname: Schroeder
authors.forename: R
authors.initials: R
authors.lastname: Levy
authors.forename: P
authors.initials: P
authors.lastname: Pouletty
authors.forename: M R
authors.initials: MR
authors.lastname: First
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001682:Biological Availability; D018592:Cross-Over Studies; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004304:Dosage Forms; D004311:Double-Blind Method; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged
chemical_list: D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine